Registered Nurse in Fort Dix, NJ Accepting Medicare
4 Registered Nurse nurses found. Showing 1 - 4
 Ms. Thelma Campbell, NURSE Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 5250 New Jersey Ave, Fort Dix, NJ 08640 Phone: 609-562-6114 |
Mrs. Anna Maria Zucker, APN-C, MSN Registered Nurse Medicare: Medicare Enrolled Practice Location: Veterans Affairs Outpatient Clinic Marshall Hall, 8th Street, Building 5437, Fort Dix, NJ 08640 Phone: 609-562-2999 Fax: 609-562-5426 |
Ms. Marilyn A Mears, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: New Jersey Ave, Walson Troop Medical Clinic Bldg 5250, Fort Dix, NJ 08640 Phone: 609-562-5707 Fax: 609-562-3153 |
Miss Christine Lee Stinner, RN,BSN Registered Nurse - Case Management Medicare: Not Enrolled in Medicare Practice Location: 5250 New Jersey Ave, Fort Dix, NJ 08640 Phone: 609-562-5075 |
News Archive
Researchers develop promising metal-based compound to fight kidney cancer
Researchers developed a promising metal-based compound that destroys kidney cancer cells, while leaving normal cells unharmed. The findings may provide a new way of treating kidney cancer, opening the potential for more potent and less toxic therapies that would give cancer patients a better quality of life.
AHCA approves Cleveland Clinic Florida applications for heart, liver and kidney transplant services
Cleveland Clinic Florida is pleased to announce that the Agency for Health Care Administration (AHCA) in Florida has approved its applications for heart, liver and kidney transplant services.
FDA approves additional intended use of Roche's cobas TaqScreen MPX Test
Roche announced today that the United States Food & Drug Administration (FDA) approved an additional intended use for its licensed nucleic acid test, to screen source plasma in pools comprised of up to 96 individual donations. The test, called the cobas® TaqScreen MPX Test for use on the cobas s 201 system, is a qualitative, in-vitro test for the simultaneous, direct detection of the human immunodeficiency virus (HIV-1 Group M RNA, HIV-1 Group O RNA , HIV-2 RNA), hepatitis C virus RNA and hepatitis B virus DNA in human plasma.
Five Prime Therapeutics relocates into new drug discovery facility in South San Francisco
Five Prime Therapeutics, Inc., a leader in biologics, has relocated into its state-of-the-art drug discovery facility in South San Francisco. The new facility provides FivePrime with a two fold increase in square footage without significant incremental rental cost. The relocation includes an expanded laboratory facility for the Company to accelerate its innovative and proprietary protein therapeutic and antibody drug discovery platform.
Impax Laboratories acquires ANDA from Watson Pharmaceuticals and Cobalt Laboratories
Impax Laboratories, Inc. today announced it acquired Abbreviated New Drug Applications (ANDA) from Watson Pharmaceuticals and Cobalt Laboratories, a subsidiary of Arrow Group.
› Verified 2 days ago
Nurse Practitioner
Registered Nurse
Licensed Practical Nurse
Physician Assistant